PRINCIPLES OF THERAPY OF IMMUNODEFICIENCES
General tactics
1. Treatment is determined by the type of immunodeficiency.
2. In severe T-cell pathology, bone marrow
transplantation is indicated.
3. With IgG deficiency, intravenous administration of solutions containing
Ig.
4. Do not administer live vaccines to immunocompromised patients and their
families. When cellular immunodeficiency is contraindicated, transfusion of
fresh blood and blood products. Ig and plasma should not be administered to
patients with selective IgA deficiency. In thrombocytopenia, intramuscular
injections should be avoided. Before the surgical or dental procedures,
antibiotics should be prescribed.
Drug therapy
1. Practically for all forms it is necessary to appoint:
- Antibiotics (for prevention and immediate treatment of infections).
- Immunostimulants (eg, levamisole, ascorbic acid, to improve the function
of neutrophils).
2. For humoral and combined immunodeficiencies - Ig substitution therapy.
3. In case of adenosine deaminase deficiency,
substitution therapy with enzyme conjugated with polyethylene glycol (Adagen).
Gene therapy (corrected T-lymphocytes of the patient) is also performed.
Complications of
immunodeficiencies
1. Autoimmune diseases.
2. Development of serum sickness in treatment with γ-globulin.
3. Development of malignant neoplasms (eg, with hypogammaglobulinemia,
thymoma may develop).
4. Severe infections.
5. "Graft versus host" reaction (usually as a result of blood
transfusion in patients with severe combined immunodeficiency).
Prevention
At primary immunodeficiencies it is necessary
mediko-genetic consultation.
Pathological tolerance
Immunological tolerance is a condition
characterized by the "tolerance" of the immune system in relation to
foreign AIs. Immunological tolerance is divided into physiological,
pathological and artificial.
Physiological tolerance
Physiological tolerance implies the
"tolerance" of the IBN system to its own AG.
The main mechanisms of development of
physiological tolerance:
1. Clonally selective
2. Insulation »
3. Elimination of autoaggressive T-lymphocytes in the thymus ("central
selection")
4. Anergy of T-lymphocytes not exposed to the action of costimulatory
molecules ("clonal anergy")
5. Depression of T-killers by T-suppressors
6. Apoptosis of lymphocytes, activated by endogenous antibodies
("clonal deletion")
- Elimination in the antenatal period (when the immune system is not yet ripe
enough) of those clones of lymphocytes that have undergone antigenic overload -
the massive effect of their own hypertension. This position was put forward by
M. Bernet and F. Fenner in the clonal-selection hypothesis formulated by them.
In the laboratory, this phenomenon is reproduced by replanting the embryo and
the fetus of the animal tissue or organ of another animal of the same species
(allograft). Repeated transplantation to an adult animal of the same transplant
does not lead to its rejection - tolerance develops to it. Such animals (in the
body of which there is genetically and antigenically a foreign tissue or organ)
are called chimeras. Similar chimerism develops in the twins and twins, which
during the prenatal period are exchanged by different blood. In the adult
state, they can freely transfuse the blood of both groups.
- Isolation of AG of a number of organs from contact with immunocytes by
structural and physiological barriers. These organs include the brain, eyes,
testes, thyroid gland, which are separated from the internal environment of the
body by hemato-tissue barriers (hemato-encephalic, hemato-ophthalmic,
hemato-thyroid). This kind of tolerance is called insulating.
- Suppression of proliferation and differentiation of autoaggressive (acting
against own cells) T-lymphocytes in the central organ of the immune system -
thymus. This phenomenon is called the central selection and elimination of
autocytotoxic lymphocytes.
- Death (apoptosis) of clones of lymphocytes activated by autoantigens. In
such a situation, T-lymphocytes, responsive to the AG of their own organism,
express Fas-receptors, which are acted upon by Fas ligands of normal cells,
which activates the apoptosis program.
Pathological tolerance
In this case, we are talking about the
"tolerance" of the system of IBS of foreign AG, most often -
bacteria, viruses, parasites, malignant tumor cells or a transplant.
The main mechanisms of pathological tolerance:
1) Immunodeficiency states and immunodeficiencies.
2) Excessive increase in activity of T-suppressors. The latter is
characterized by inhibition of the maturation of the effector cells of the
immune system: T-killers, natural killers, plasma cells.
3) Inhibition or blockade of cytotoxic reactions of cellular immunity to
the corresponding AH (most often tumor cells, grafts or virus-containing cells)
as a result of "screening" of antigens with antibodies.
4) Overload of immunocytes by excess of foreign AGs formed in the body or
introduced into it from outside. This can be observed in the synthesis of
abnormal proteins in the liver, amyloidosis, denaturation of protein molecules
with massive burns, the introduction of a large number of protein-containing
solutions (whole blood, plasma).
5) Death of cytotoxic T-lymphocytes with the development of T-cell
immunodeficiency. This is observed when other cells (eg, tumor cells) express
Fas ligands. The latter, interacting with Fas-receptors of cytotoxic
T-lymphocytes, activate the program of their apoptosis.
Artificial Tolerance
Induced (artificial, medical) tolerance is
reproduced by means of influences that suppress the activity of the immune
system. Usually, ionizing radiation, high doses of cytostatics and
immunosuppressants are used for this purpose. To create a state of artificial
tolerance, special cells (impermeable to immunocytes) implanted under the skin,
mucous membrane, into muscles or body cavities are also used. A homogenate or
fragments of foreign tissue (for example, the endocrine gland to eliminate the
deficiency of endogenous hormone) are placed in the chamber. This kind of
tolerance is called insulating.
The state of induced tolerance is used to increase
the success of organ and tissue transplantation, allergy treatment, immune
auto-aggression diseases, endocrine insufficiency and some other conditions.
The "graft versus
host" reaction
The "graft versus host" reaction
develops when the donor tissues containing immunocytes (for example, bone
marrow, spleen, leukocyte mass) are transplanted to the recipient (the
"host").
Conditions for the development of "graft
versus host" reactions
- Genetic alienity of the donor and recipient.
- The presence of a large number of lymphocytes in the transplant.
- Inability of the recipient to destroy or reject this transplant.
Manifestations
The "graft versus host" reaction is
characterized by the defeat of the immune system of the recipient and the
development of immunodeficiency in connection with it. In addition to the immune
system, other organs are always damaged: skin, muscles, gastrointestinal tract,
liver, kidneys.
The lesions of these organs and tissues are
manifested by necrotic and dystrophic changes, the development of deficiency of
their functions, lymphopenia, anemia, thrombocytopenia, dyspeptic disorders
(nausea, vomiting, diarrhea), liver enlargement.
- In adults, the described condition is called homologous or
transplantation disease.
- Wound disease develops in children - a small-growth disease (from
English, runt, the smallest individual). The latter is associated with a
violation of the child's physical development, multiple organ failure, a
tendency to develop infectious diseases and neoplasms.
Post Comment
No comments